Found: 2

Select item for more details and to access through your institution.

  • Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains.

    Published in:
    eLife, 2021, p. 1, doi. 10.7554/eLife.69317
    By:
    • Faulkner, Nikhil;
    • Ng, Kevin W.;
    • Wu, Mary Y.;
    • Harvey, Ruth;
    • Margaritis, Marios;
    • Paraskevopoulou, Stavroula;
    • Houlihan, Catherine;
    • Hussain, Saira;
    • Greco, Maria;
    • Bolland, William;
    • Warchal, Scott;
    • Heaney, Judith;
    • Rickman, Hannah;
    • Spyer, Moria;
    • Frampton, Daniel;
    • Byott, Matthew;
    • de Oliveira, Tulio;
    • Sigal, Alex;
    • Kjaer, Svend;
    • Swanton, Charles
    Publication type:
    Article

  • SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies.

    Published in:
    Science Translational Medicine, 2022, v. 14, n. 655, p. 1, doi. 10.1126/scitranslmed.abn3715
    By:
    • Ng, Kevin W.;
    • Faulkner, Nikhil;
    • Finsterbusch, Katja;
    • Wu, Mary;
    • Harvey, Ruth;
    • Hussain, Saira;
    • Greco, Maria;
    • Liu, Yafei;
    • Kjaer, Svend;
    • Swanton, Charles;
    • Gandhi, Sonia;
    • Beale, Rupert;
    • Gamblin, Steve J.;
    • Cherepanov, Peter;
    • McCauley, John;
    • Daniels, Rodney;
    • Howell, Michael;
    • Arase, Hisashi;
    • Wack, Andreas;
    • Bauer, David L.V.
    Publication type:
    Article